claim: A Good Day to Die Hard was written.
evidence: Burosumab -LRB- INN -RRB- known as KRN23 is a human monoclonal antibody designed for the treatment of X-linked hypophosphatemia .. INN. International Nonproprietary Name. X-linked hypophosphatemia. X-linked hypophosphatemia. This drug was developed by Ultragenyx and is in a collaborative license agreement with Kyowa Hakko Kirin .